Molecular stratification of idiopathic nephrotic syndrome (original) (raw)

• Banh, T. H. et al. Ethnic differences in incidence and outcomes of childhood nephrotic syndrome. Clin. J. Am. Soc. Nephrol. 11, 1760–1768 (2016).
  CAS PubMed PubMed Central Google Scholar
• Kim, J. S. et al. High incidence of initial and late steroid resistance in childhood nephrotic syndrome. Kidney Int. 68, 1275–1281 (2005).
  CAS PubMed Google Scholar
• Bierzynska, A. et al. Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management. Kidney Int. 91, 937–947 (2017).
  PubMed Google Scholar
• Saleem, M. A. One hundred ways to kill a podocyte. Nephrol. Dial. Transpl. 30, 1266–1271 (2015).
  CAS Google Scholar
• Hunte, W., al-Ghraoui, F. & Cohen, R. J. Secondary syphilis and the nephrotic syndrome. J. Am. Soc. Nephrol. 3, 1351–1355 (1993).
  CAS PubMed Google Scholar
• Becker, C. G. et al. Nephrotic syndrome after contact with mercury. A report of five cases, three after the use of ammoniated mercury ointment. Arch. Intern. Med. 110, 178–186 (1962).
  CAS PubMed Google Scholar
• Maas, R. J. et al. Minimal change disease and idiopathic FSGS: manifestations of the same disease. Nat. Rev. Nephrol. 12, 768–776 (2016).
  PubMed Google Scholar
• Report of the International Study of Kidney Disease in Children. Minimal change nephrotic syndrome in children: deaths during the first 5 to 15 years’ observation. Pediatrics 73, 497–501 (1984).
  Google Scholar
• Niaudet, P. Long-term outcome of children with steroid-sensitive idiopathic nephrotic syndrome. Clin. J. Am. Soc. Nephrol. 4, 1547–1548 (2009).
  PubMed Google Scholar
• Vivarelli, M. et al. Minimal change disease. Clin. J. Am. Soc. Nephrol. 12, 332–345 (2017).
  CAS PubMed Google Scholar
• D’Agati, V. D. et al. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am. J. Kidney Dis. 43, 368–382 (2004).
  PubMed Google Scholar
• Trautmann, A. et al. Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort. Clin. J. Am. Soc. Nephrol. 10, 592–600 (2015).
  PubMed PubMed Central Google Scholar
• Bagga, A., Sinha, A. & Moudgil, A. Rituximab in patients with the steroid-resistant nephrotic syndrome. N. Engl. J. Med. 356, 2751–2752 (2007).
  CAS PubMed Google Scholar
• Iijima, K. et al. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 384, 1273–1281 (2014).
  CAS PubMed Google Scholar
• Sinha, A. et al. Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome. Nephrol. Dial. Transpl. 30, 96–106 (2015).
  CAS Google Scholar
• Trachtman, H. et al. DUET: a phase 2 study evaluating the efficacy and safety of sparsentan in patients with FSGS. J. Am. Soc. Nephrol. 29, 2745–2754 (2018).
  CAS PubMed PubMed Central Google Scholar
• Fan, X. et al. SLIT2/ROBO2 signaling pathway inhibits nonmuscle myosin IIA activity and destabilizes kidney podocyte adhesion. JCI Insight 1, e86934 (2016).
  PubMed PubMed Central Google Scholar
• Welsh, G. I. & Saleem, M. A. The podocyte cytoskeleton–key to a functioning glomerulus in health and disease. Nat. Rev. Nephrol. 8, 14–21 (2012).
  CAS Google Scholar
• Kreidberg, J. A. et al. WT-1 is required for early kidney development. Cell 74, 679–691 (1993).
  CAS PubMed Google Scholar
• Kestila, M. et al. Positionally cloned gene for a novel glomerular protein–nephrin–is mutated in congenital nephrotic syndrome. Mol. Cell 1, 575–582 (1998).
  CAS PubMed Google Scholar
• Welsh, G. I. & Saleem, M. A. Nephrin — signature molecule of the glomerular podocyte? J. Pathol. 220, 328–337 (2010).
  CAS PubMed Google Scholar
• Simons, M. et al. Involvement of lipid rafts in nephrin phosphorylation and organization of the glomerular slit diaphragm. Am. J. Pathol. 159, 1069–1077 (2001).
  CAS PubMed PubMed Central Google Scholar
• Schwarz, K. et al. Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J. Clin. Invest. 108, 1621–1629 (2001).
  CAS PubMed PubMed Central Google Scholar
• Weber, S. et al. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int. 66, 571–579 (2004).
  CAS PubMed Google Scholar
• Shih, N. Y. et al. Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 286, 312–315 (1999).
  CAS PubMed Google Scholar
• Bierzynska, A. et al. MAGI2 mutations cause congenital nephrotic syndrome. J. Am. Soc. Nephrol. 28, 1614–1621 (2017).
  CAS PubMed Google Scholar
• van Duijn, T. J. et al. Rac1 recruits the adapter protein CMS/CD2AP to cell-cell contacts. J. Biol. Chem. 285, 20137–20146 (2010).
  PubMed PubMed Central Google Scholar
• Huber, T. B. et al. Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling. Mol. Cell. Biol. 23, 4917–4928 (2003).
  CAS PubMed PubMed Central Google Scholar
• Akilesh, S., Koziell, A. & Shaw, A. S. Basic science meets clinical medicine: identification of a CD2AP-deficient patient. Kidney Int. 72, 1181–1183 (2007).
  CAS PubMed Google Scholar
• Gigante, M. et al. CD2AP mutations are associated with sporadic nephrotic syndrome and focal segmental glomerulosclerosis (FSGS). Nephrol. Dial. Transpl. 24, 1858–1864 (2009).
  CAS Google Scholar
• Akilesh, S. et al. Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis. J. Clin. Invest. 121, 4127–4137 (2011).
  CAS PubMed PubMed Central Google Scholar
• Gee, H. Y. et al. ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling. J. Clin. Invest. 123, 3243–3253 (2013).
  CAS PubMed PubMed Central Google Scholar
• Harris, J. J. et al. Active proteases in nephrotic plasma lead to a podocin-dependent phosphorylation of VASP in podocytes via protease activated receptor-1. J. Pathol. 229, 660–671 (2013).
  CAS PubMed Google Scholar
• Pozzi, A. et al. Beta1 integrin expression by podocytes is required to maintain glomerular structural integrity. Dev. Biol. 316, 288–301 (2008).
  CAS PubMed PubMed Central Google Scholar
• Kanasaki, K. et al. Integrin beta1-mediated matrix assembly and signaling are critical for the normal development and function of the kidney glomerulus. Dev. Biol. 313, 584–593 (2008).
  CAS PubMed Google Scholar
• Wei, C. et al. Modification of kidney barrier function by the urokinase receptor. Nat. Med. 14, 55–63 (2008).
  CAS PubMed Google Scholar
• Wei, C. et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat. Med. 17, 952–960 (2011).
  CAS PubMed PubMed Central Google Scholar
• Lin, Y., Rao, J., Zha, X. & Xu, H. Angiopoietin-like 3 induces podocyte F-actin rearrangement through integrin alpha(V)beta(3)/FAK/PI3K pathway-mediated Rac1 activation. Biomed Res. Int. 2013, 135608 (2013).
  PubMed PubMed Central Google Scholar
• Ashraf, S. et al. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption. J. Clin. Invest. 123, 5179–5189 (2013).
  CAS PubMed PubMed Central Google Scholar
• Heeringa, S. F. et al. COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J. Clin. Invest. 121, 2013–2024 (2011).
  CAS PubMed PubMed Central Google Scholar
• Diomedi-Camassei, F. et al. COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement. J. Am. Soc. Nephrol. 18, 2773–2780 (2007).
  CAS PubMed Google Scholar
• Lopez, L. C. et al. Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. Am. J. Hum. Genet. 79, 1125–1129 (2006).
  CAS PubMed PubMed Central Google Scholar
• Braun, D. A. et al. Mutations in nuclear pore genes NUP93, NUP205 and XPO5 cause steroid-resistant nephrotic syndrome. Nat. Genet. 48, 457–465 (2016).
  CAS PubMed PubMed Central Google Scholar
• Shalhoub, R. J. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 2, 556–560 (1974).
  CAS PubMed Google Scholar
• Eremina, V. & Quaggin, S. E. The role of VEGF-A in glomerular development and function. Curr. Opin. Nephrol. Hypertens. 13, 9–15 (2004).
  CAS PubMed Google Scholar
• Daehn, I. et al. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis. J. Clin. Invest. 124, 1608–1621 (2014).
  CAS PubMed PubMed Central Google Scholar
• Eremina, V. et al. VEGF inhibition and renal thrombotic microangiopathy. N. Engl. J. Med. 358, 1129–1136 (2008).
  CAS PubMed PubMed Central Google Scholar
• Eremina, V. et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J. Clin. Invest. 111, 707–716 (2003).
  CAS PubMed PubMed Central Google Scholar
• Keir, L. S. et al. VEGF regulates local inhibitory complement proteins in the eye and kidney. J. Clin. Invest. 127, 199–214 (2017).
  PubMed Google Scholar
• Guan, Z., VanBeusecum, J. P. & Inscho, E. W. Endothelin and the renal microcirculation. Semin. Nephrol. 35, 145–155 (2015).
  CAS PubMed PubMed Central Google Scholar
• Lenoir, O. et al. Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis. J. Am. Soc. Nephrol. 25, 1050–1062 (2014).
  CAS PubMed PubMed Central Google Scholar
• Barton, M. Therapeutic potential of endothelin receptor antagonists for chronic proteinuric renal disease in humans. Biochim. Biophys. Acta 1802, 1203–1213 (2010).
  CAS PubMed Google Scholar
• Coward, R. J. et al. The human glomerular podocyte is a novel target for insulin action. Diabetes 54, 3095–3102 (2005).
  CAS PubMed Google Scholar
• Welsh, G. I. et al. Insulin signaling to the glomerular podocyte is critical for normal kidney function. Cell Metab. 12, 329–340 (2010).
  CAS PubMed PubMed Central Google Scholar
• Keir, L. S., Marks, S. D. & Kim, J. J. Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies. Drug Des. Dev. Ther. 6, 195–208 (2012).
  CAS Google Scholar
• Psotka, M. A. et al. Shiga toxin 2 targets the murine renal collecting duct epithelium. Infect. Immun. 77, 959–969 (2009).
  CAS PubMed PubMed Central Google Scholar
• Davin, J. C. The glomerular permeability factors in idiopathic nephrotic syndrome. Pediatr. Nephrol. 31, 207–215 (2016).
  PubMed Google Scholar
• Bierzynska, A. & Saleem, M. A. Deriving and understanding the risk of post-transplant recurrence of nephrotic syndrome in the light of current molecular and genetic advances. Pediatr. Nephrol. 33, 2027–2035 (2018).
  PubMed Google Scholar
• Gallon, L. et al. Resolution of recurrent focal segmental glomerulosclerosis after retransplantation. N. Engl. J. Med. 366, 1648–1649 (2012).
  CAS PubMed Google Scholar
• Hinkes, B. et al. Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat. Genet. 38, 1397–1405 (2006).
  CAS PubMed Google Scholar
• Wasilewska, A. M., Kuroczycka-Saniutycz, E. & Zoch-Zwierz, W. Effect of cyclosporin A on proteinuria in the course of glomerulopathy associated with WT1 mutations. Eur. J. Pediatr. 170, 389–391 (2011).
  CAS PubMed Google Scholar
• Kuusniemi, A. M. et al. Plasma exchange and retransplantation in recurrent nephrosis of patients with congenital nephrotic syndrome of the Finnish type (NPHS1). Transplantation 83, 1316–1323 (2007).
  PubMed Google Scholar
• Gbadegesin, R. et al. A new locus for familial FSGS on chromosome 2P. J. Am. Soc. Nephrol. 21, 1390–1397 (2010).
  CAS PubMed PubMed Central Google Scholar
• Bertelli, R. et al. Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. Am. J. Kidney Dis. 41, 1314–1321 (2003).
  CAS PubMed Google Scholar
• Billing, H. et al. NPHS2 mutation associated with recurrence of proteinuria after transplantation. Pediatr. Nephrol. 19, 561–564 (2004).
  PubMed Google Scholar
• Becker-Cohen, R. et al. Recurrent nephrotic syndrome in homozygous truncating NPHS2 mutation is not due to anti-podocin antibodies. Am. J. Transpl. 7, 256–260 (2007).
  CAS Google Scholar
• Hocker, B. et al. Recurrence of proteinuria 10 years post-transplant in NPHS2-associated focal segmental glomerulosclerosis after conversion from cyclosporin A to sirolimus. Pediatr. Nephrol. 21, 1476–1479 (2006).
  PubMed Google Scholar
• Ruf, R. G. et al. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J. Am. Soc. Nephrol. 15, 722–732 (2004).
  PubMed Google Scholar
• Caridi, G. et al. Heterozygous NPHS1 or NPHS2 mutations in responsive nephrotic syndrome and the multifactorial origin of proteinuria. Kidney Int. 66, 1715–1716 (2004).
  PubMed Google Scholar
• Dorval, G. et al. Clinical and genetic heterogeneity in familial steroid-sensitive nephrotic syndrome. Pediatr. Nephrol. 33, 473–483 (2018).
  PubMed Google Scholar
• Gee, H. Y. et al. Mutations in EMP2 cause childhood-onset nephrotic syndrome. Am. J. Hum. Genet. 94, 884–890 (2014).
  CAS PubMed PubMed Central Google Scholar
• Gee, H. Y. et al. KANK deficiency leads to podocyte dysfunction and nephrotic syndrome. J. Clin. Investig. 125, 2375–2384 (2015).
  PubMed PubMed Central Google Scholar
• Xing, C. Y. et al. Direct effects of dexamethasone on human podocytes. Kidney Int. 70, 1038–1045 (2006).
  CAS PubMed Google Scholar
• Faul, C. et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat. Med. 14, 931–938 (2008).
  CAS PubMed PubMed Central Google Scholar
• McCarthy, H. J. et al. Simultaneous sequencing of 24 genes associated with steroid-resistant nephrotic syndrome. Clin. J. Am. Soc. Nephrol. 8, 637–648 (2013).
  CAS PubMed PubMed Central Google Scholar
• Sen, E. S. et al. Clinical genetic testing using a custom-designed steroid-resistant nephrotic syndrome gene panel: analysis and recommendations. J. Med. Genet. 54, 795–804 (2017).
  CAS PubMed Google Scholar
• Lee, H. et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA 312, 1880–1887 (2014).
  PubMed PubMed Central Google Scholar
• Sadowski, C. E. et al. A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J. Am. Soc. Nephrol. 26, 1279–1289 (2015).
  CAS PubMed Google Scholar
• Gribouval, O. et al. Identification of genetic causes for sporadic steroid-resistant nephrotic syndrome in adults. Kidney Int. 94, 1013–1022 (2018).
  CAS PubMed Google Scholar
• Yao, T. et al. Integration of genetic testing and pathology for the diagnosis of adults with FSGS. Clin. J. Am. Soc. Nephrol. 14, 213–223 (2019).
  PubMed PubMed Central Google Scholar
• Robson, K. J. et al. HLA and kidney disease: from associations to mechanisms. Nat. Rev. Nephrol. 14, 636–655 (2018).
  CAS PubMed Google Scholar
• Jia, X. Y. et al. Strong association of the HLA-DR/DQ locus with childhood steroid-sensitive nephrotic syndrome in the Japanese population. J. Am. Soc. Nephrol. 29, 2189–2199 (2018).
  CAS PubMed PubMed Central Google Scholar
• Debiec, H. et al. Transethnic, genome-wide analysis reveals immune-related risk alleles and phenotypic correlates in pediatric steroid-sensitive nephrotic syndrome. J. Am. Soc. Nephrol. 29, 2000–2013 (2018).
  CAS PubMed PubMed Central Google Scholar
• Crawford, B. D. et al. Evaluating Mendelian nephrotic syndrome genes for evidence for risk alleles or oligogenicity that explain heritability. Pediatr. Nephrol. 32, 467–476 (2017).
  PubMed Google Scholar
• Kienzl-Wagner, K., Waldegger, S. & Schneeberger, S. Disease recurrence-the sword of Damocles in kidney transplantation for primary focal segmental glomerulosclerosis. Front. Immunol. 10, 1669 (2019).
  PubMed PubMed Central Google Scholar
• Ding, W. Y. et al. Initial steroid sensitivity in children with steroid-resistant nephrotic syndrome predicts post-transplant recurrence. J. Am. Soc. Nephrol. 25, 1342–1348 (2014).
  CAS PubMed PubMed Central Google Scholar
• Sinha, A. et al. Disease course in steroid sensitive nephrotic syndrome. Indian Pediatr. 49, 881–887 (2012).
  PubMed Google Scholar
• Buscher, A. K. et al. Rapid response to cyclosporin A and favorable renal outcome in nongenetic versus genetic steroid-resistant nephrotic syndrome. Clin. J. Am. Soc. Nephrol. 11, 245–253 (2016).
  PubMed Google Scholar
• Savin, V. J. et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N. Engl. J. Med. 334, 878–883 (1996).
  CAS PubMed Google Scholar
• Cattran, D. et al. Serial estimates of serum permeability activity and clinical correlates in patients with native kidney focal segmental glomerulosclerosis. J. Am. Soc. Nephrol. 14, 448–453 (2003).
  CAS PubMed Google Scholar
• Trachtman, H. et al. Glomerular permeability activity: prevalence and prognostic value in pediatric patients with idiopathic nephrotic syndrome. Am. J. Kidney Dis. 44, 604–610 (2004).
  PubMed Google Scholar
• Saleem, M. A. et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J. Am. Soc. Nephrol. 13, 630–638 (2002).
  CAS PubMed Google Scholar
• Srivastava, P. et al. Development of a novel cell-based assay to diagnose recurrent focal segmental glomerulosclerosis patients. Kidney Int. 95, 708–716 (2019).
  PubMed PubMed Central Google Scholar
• Kitzler, T. M. et al. Use of genomic and functional analysis to characterize patients with steroid-resistant nephrotic syndrome. Pediatr. Nephrol. 33, 1741–1750 (2018).
  PubMed Google Scholar
• Bitzan, M. et al. TNF alpha pathway blockade ameliorates toxic effects of FSGS plasma on podocyte cytoskeleton and beta 3 integrin activation. Pediatr. Nephrol. 27, 2217–2226 (2012).
  PubMed Google Scholar
• Coward, R. J. et al. Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, podocin, and CD2 associated protein in cultured human podocytes. J. Am. Soc. Nephrol. 16, 629–637 (2005).
  CAS PubMed Google Scholar
• May, C. J. et al. Human Th17 cells produce a soluble mediator that increases podocyte motility via signalling pathways which mimic PAR-1 activation. Am. J. Physiol. Renal Physiol. 317, F913–F921 (2019).
  PubMed PubMed Central Google Scholar
• Yu, C. C. et al. Abatacept in B7-1-positive proteinuric kidney disease. N. Engl. J. Med. 369, 2416–2423 (2013).
  CAS PubMed PubMed Central Google Scholar
• Novelli, R., Benigni, A. & Remuzzi, G. The role of B7-1 in proteinuria of glomerular origin. Nat. Rev. Nephrol. 14, 589–596 (2018).
  CAS PubMed Google Scholar
• Kim, E. Y., Roshanravan, H. & Dryer, S. E. Changes in podocyte TRPC channels evoked by plasma and sera from patients with recurrent FSGS and by putative glomerular permeability factors. Biochim. Biophys. Acta 1863, 2342–2354 (2017).
  CAS PubMed Central Google Scholar
• Morath, C. et al. Management of severe recurrent focal segmental glomerulosclerosis through circulating soluble urokinase receptor modification. Am. J. Ther. 20, 226–229 (2013).
  PubMed Google Scholar
• Winn, M. P. et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 308, 1801–1804 (2005).
  CAS PubMed Google Scholar
• Farmer, L. K., et al. TRPC6 binds to and activates calpain, independent of its channel activity, and regulates podocyte cytoskeleton, cell adhesion, and motility. J. Am. Soc. Nephrol. https://doi.org/10.1681/ASN.2018070729 (2019).
  PubMed PubMed Central Google Scholar
• Verheijden, K. A. T. et al. The calcium-dependent protease calpain-1 links TRPC6 activity to podocyte injury. J. Am. Soc. Nephrol. 29, 2099–2109 (2018).
  CAS PubMed PubMed Central Google Scholar
• Veit, G. et al. Structure-guided combination therapy to potently improve the function of mutant CFTRs. Nat. Med. 24, 1732–1742 (2018).
  CAS PubMed PubMed Central Google Scholar
• Roselli, S. et al. Plasma membrane targeting of podocin through the classical exocytic pathway: effect of NPHS2 mutations. Traffic 5, 37–44 (2004).
  CAS PubMed Google Scholar
• Nathwani, A. C., Davidoff, A. M. & Tuddenham, E. G. D. Advances in gene therapy for hemophilia. Hum. Gene Ther. 28, 1004–1012 (2017).
  CAS PubMed Google Scholar
• Mendell, J. R. et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N. Engl. J. Med. 377, 1713–1722 (2017).
  CAS PubMed Google Scholar
• Hale, L. J. et al. 3D organoid-derived human glomeruli for personalised podocyte disease modelling and drug screening. Nat. Commun. 9, 5167 (2018).
  PubMed PubMed Central Google Scholar
• Takasato, M. et al. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature 526, 564–568 (2015).
  CAS PubMed Google Scholar
• Morizane, R. et al. Nephron organoids derived from human pluripotent stem cells model kidney development and injury. Nat. Biotechnol. 33, 1193–1200 (2015).
  CAS PubMed PubMed Central Google Scholar
• Sharmin, S. et al. Human induced pluripotent stem cell-derived podocytes mature into vascularized glomeruli upon experimental transplantation. J. Am. Soc. Nephrol. 27, 1778–1791 (2016).
  CAS PubMed Google Scholar
• Taguchi, A. & Nishinakamura, R. Higher-order kidney organogenesis from pluripotent stem cells. Cell Stem Cell 21, 730–773 (2017).
  CAS PubMed Google Scholar
• Xinaris, C. et al. Functional human podocytes generated in organoids from amniotic fluid stem cells. J. Am. Soc. Nephrol. 27, 1400–1411 (2016).
  CAS PubMed Google Scholar
• Merchant, M. L. et al. Isolation and characterization of urinary extracellular vesicles: implications for biomarker discovery. Nat. Rev. Nephrol. 13, 731–749 (2017).
  CAS PubMed PubMed Central Google Scholar
• Lai, Z. W., Petrera, A. & Schilling, O. Protein amino-terminal modifications and proteomic approaches for N-terminal profiling. Curr. Opin. Chem. Biol. 24, 71–79 (2015).
  CAS PubMed Google Scholar
• Lange, P. F. & Overall, C. M. Protein TAILS: when termini tell tales of proteolysis and function. Curr. Opin. Chem. Biol. 17, 73–82 (2013).
  CAS PubMed Google Scholar
• Turk, B. Targeting proteases: successes, failures and future prospects. Nat. Rev. Drug Discov. 5, 785–799 (2006).
  CAS PubMed Google Scholar
• Wiita, A. P. et al. Circulating proteolytic signatures of chemotherapy-induced cell death in humans discovered by N-terminal labeling. Proc. Natl Acad. Sci. USA 111, 7594–7599 (2014).
  CAS PubMed PubMed Central Google Scholar
• Meyer-Schwesinger, C. et al. Ubiquitin C-terminal hydrolase-l1 activity induces polyubiquitin accumulation in podocytes and increases proteinuria in rat membranous nephropathy. Am. J. Pathol. 178, 2044–2057 (2011).
  CAS PubMed PubMed Central Google Scholar
• Meyer-Schwesinger, C. The ubiquitin-proteasome system in kidney physiology and disease. Nat. Rev. Nephrol. 15, 393–411 (2019).
  PubMed Google Scholar
• Spath, M. R. et al. The proteome microenvironment determines the protective effect of preconditioning in cisplatin-induced acute kidney injury. Kidney Int. 95, 333–349 (2019).
  PubMed Google Scholar
• Karpman, D., Stahl, A. L. & Arvidsson, I. Extracellular vesicles in renal disease. Nat. Rev. Nephrol. 13, 545–562 (2017).
  CAS PubMed Google Scholar
• Hogan, M. C. et al. Subfractionation, characterization, and in-depth proteomic analysis of glomerular membrane vesicles in human urine. Kidney Int. 85, 1225–1237 (2014).
  CAS PubMed Google Scholar
• Erkan, E. et al. Distinct urinary lipid profile in children with focal segmental glomerulosclerosis. Pediatr. Nephrol. 31, 581–588 (2016).
  PubMed Google Scholar
• Shah, L., et al. LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients. Pediatr. Nephrol. https://doi.org/10.1007/s00467-019-04296-6 (2019).
  PubMed Google Scholar
• Kaisar, M. et al. Plasma degradome affected by variable storage of human blood. Clin. Proteom. 13, 26 (2016).
  Google Scholar
• Trautmann, A., Lipska-Zietkiewicz, B. S. & Schaefer, F. Exploring the clinical and genetic spectrum of steroid resistant nephrotic syndrome: the PodoNet Registry. Front. Pediatr. 6, 200 (2018).
  PubMed PubMed Central Google Scholar
• Gadegbeku, C. A. et al. Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. Kidney Int. 83, 749–756 (2013).
  PubMed PubMed Central Google Scholar
• Dossier, C. et al. Five-year outcome of children with idiopathic nephrotic syndrome: the NEPHROVIR population-based cohort study. Pediatr. Nephrol. 34, 671–678 (2019).
  PubMed Google Scholar
• Scheufele, E. et al. tranSMART: an open source knowledge management and high content data analytics platform. AMIA Jt. Summits Transl. Sci. Proc. 2014, 96–101 (2014).
  PubMed PubMed Central Google Scholar
• Ding, W. Y. et al. Big data and stratified medicine: what does it mean for children? Arch. Dis. Child. 104, 389–394 (2019).
  PubMed Google Scholar
• Banchereau, R. et al. Personalized immunomonitoring uncovers molecular networks that stratify lupus patients. Cell 165, 551–565 (2016).
  CAS PubMed PubMed Central Google Scholar
• Agius, P., Ying, Y. & Campbell, C. Bayesian unsupervised learning with multiple data types. Stat. Appl. Genet. Mol. Biol. 8, 27 (2009).
  Google Scholar
• Curtis, C. et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486, 346–352 (2012).
  CAS PubMed PubMed Central Google Scholar
• Perez, V. et al. Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis. BMC Nephrol. 18, 49 (2017).
  PubMed PubMed Central Google Scholar
• Choi, Y. W. et al. Potential urine proteomics biomarkers for primary nephrotic syndrome. Clin. Proteom. 14, 18 (2017).
  Google Scholar
• Huang, Z., Zhang, Y., Zhou, J. & Zhang, Y. Urinary exosomal miR-193a can be a potential biomarker for the diagnosis of primary focal segmental glomerulosclerosis in children. Biomed. Res. Int. 2017, 7298160 (2017).
  PubMed PubMed Central Google Scholar
• Ramezani, A. et al. Circulating and urinary microRNA profile in focal segmental glomerulosclerosis: a pilot study. Eur. J. Clin. Invest. 45, 394–404 (2015).
  CAS PubMed PubMed Central Google Scholar
• Lee, J. E. et al. Systematic biomarker discovery and coordinative validation for different primary nephrotic syndromes using gas chromatography-mass spectrometry. J. Chromatogr. A 1453, 105–115 (2016).
  CAS PubMed Google Scholar
• Sui, W. et al. Circulating microRNAs as potential biomarkers for nephrotic syndrome. Iran. J. Kidney Dis. 8, 371–376 (2014).
  PubMed Google Scholar
• Lu, M. et al. Differentially expressed microRNAs in kidney biopsies from various subtypes of nephrotic children. Exp. Mol. Pathol. 99, 590–595 (2015).
  CAS PubMed Google Scholar
• Nafar, M. et al. The novel diagnostic biomarkers for focal segmental glomerulosclerosis. Int. J. Nephrol. 2014, 574261 (2014).
  PubMed PubMed Central Google Scholar
• Pant, P. et al. Serum sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis of patients with membranous nephropathy and focal and segmental glomerulosclerosis. Saudi J. Kidney Dis. Transpl. 27, 539–545 (2016).
  PubMed Google Scholar
• Suresh, C. P. et al. Differentially expressed urinary biomarkers in children with idiopathic nephrotic syndrome. Clin. Exp. Nephrol. 20, 273–283 (2016).
  CAS PubMed Google Scholar
• Kalantari, S. et al. Predictive urinary biomarkers for steroid-resistant and steroid-sensitive focal segmental glomerulosclerosis using high resolution mass spectrometry and multivariate statistical analysis. BMC Nephrol. 15, 141 (2014).
  PubMed PubMed Central Google Scholar
• Nickavar, A. et al. Urine neutrophil gelatinase associated lipocalin to creatinine ratio: a novel index for steroid response in idiopathic nephrotic syndrome. Indian J. Pediatr. 83, 18–21 (2016).
  PubMed Google Scholar
• Gopal, N. et al. Assay of urinary protein-bound sialic acid can differentiate steroidsensitive nephrotic syndrome from steroid-resistant cases. Saudi J. Kidney Dis. Transpl. 27, 37–40 (2016).
  PubMed Google Scholar
• Bennett, M. R. et al. Urinary vitamin D-binding protein as a biomarker of steroid-resistant nephrotic syndrome. Biomark. Insights 11, 1–6 (2016).
  CAS PubMed PubMed Central Google Scholar
• Badr, H. S., El-Hawy, M. A. & Helwa, M. A. P-glycoprotein activity in steroid-responsive vs. steroid-resistant nephrotic syndrome. Indian J. Pediatr. 83, 1222–1226 (2016).
  PubMed Google Scholar
• Turolo, S. et al. SXR rs3842689: a prognostic factor for steroid sensitivity or resistance in pediatric idiopathic nephrotic syndrome. Pharmacogenomics 17, 1227–1233 (2016).
  CAS PubMed Google Scholar
• Mishra, O. P. et al. Toll-like receptor 3 (TLR-3), TLR-4 and CD80 expression in peripheral blood mononuclear cells and urinary CD80 levels in children with idiopathic nephrotic syndrome. Pediatr. Nephrol. 32, 1355–1361 (2017).
  PubMed Google Scholar
• Gopal, N. et al. Assay of urinary protein carbonyl content can predict the steroid dependence and resistance in children with idiopathic nephrotic syndrome. Saudi J. Kidney Dis. Transpl. 28, 268–272 (2017).
  PubMed Google Scholar
• Bennett, M. R. et al. A novel biomarker panel to identify steroid resistance in childhood idiopathic nephrotic syndrome. Biomark. Insights 12, 1–11 (2017).
  CAS Google Scholar
• Watany, M. M. & El-Horany, H. E. Nephronectin (NPNT) and the prediction of nephrotic syndrome response to steroid treatment. Eur. J. Hum. Genet. 26, 1354–1360 (2018).
  CAS PubMed PubMed Central Google Scholar
• Andersen, R. F. et al. Plasma and urine proteomic profiles in childhood idiopathic nephrotic syndrome. Proteom. Clin. Appl. 6, 382–393 (2012).
  CAS Google Scholar
• Chan, C. Y. et al. T lymphocyte activation markers as predictors of responsiveness to rituximab among patients with FSGS. Clin. J. Am. Soc. Nephrol. 11, 1360–1368 (2016).
  CAS PubMed PubMed Central Google Scholar
• Kuribayashi-Okuma, E. et al. Proteomics approach identifies factors associated with the response to low-density lipoprotein apheresis therapy in patients with steroid-resistant nephrotic syndrome. Ther. Apher. Dial. 20, 174–182 (2016).
  CAS PubMed Google Scholar
• Kalantari, S. et al. Urinary prognostic biomarkers in patients with focal segmental glomerulosclerosis. Nephrourol. Mon. 6, e16806 (2014).
  PubMed PubMed Central Google Scholar
• Lopez-Hellin, J. et al. A form of apolipoprotein a-I is found specifically in relapses of focal segmental glomerulosclerosis following transplantation. Am. J. Transpl. 13, 493–500 (2013).
  CAS Google Scholar
• Puig-Gay, N. et al. Apolipoprotein A-Ib as a biomarker of focal segmental glomerulosclerosis recurrence after kidney transplantation: diagnostic performance and assessment of its prognostic value – a multi-centre cohort study. Transpl. Int. 32, 313–322 (2019).
  CAS PubMed Google Scholar